Noticias y vídeos - OPTION CARE HEALTH INC.

BANNOCKBURN, Ill., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today that it has completed the reverse 1-for-4 stock split of its shares of common stock, as previously disclosed in the Company’s filings with the Securities and Exchange Commission. As of market open on February 3, 2020, the Company’s common stock,...

BANNOCKBURN, Ill., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent provider of home and alternate site infusion therapy services, will present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020. John C. Rademacher, Option Care Health’s President & Chief Executive Officer is scheduled to present at 4:30 p.m. PT. A live audio webcast and replay of this presentation will be available at...

BANNOCKBURN, Ill., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent provider of home and alternate treatment site infusion therapy services, will present at the Bank of America Merrill Lynch 2019 Leveraged Finance Conference on December 3, 2019. Mike Shapiro, Option Care Health’s Chief Financial Officer, is scheduled to present at 10:50 a.m. ET. A live audio webcast and replay of this presentation will be available at...

BANNOCKBURN, Ill., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Option Care Health, Inc. , the nation’s largest independent provider of home and alternate treatment site infusion therapy services, has been chosen by Highmark health plan as a preferred provider of factor drug products for the treatment and management of plan members with hemophilia, beginning in January 2020. A national leader in treating bleeding disorders, Option Care Health provides specialized intravenous (IV) infusion of clotting...

BANNOCKBURN, Ill., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (Nasdaq: BIOS), the nation’s largest independent provider of home and alternate site infusion services, today announced financial results for the third quarter ended September 30, 2019. Transaction Highlights Completed merger between legacy Option Care Enterprises, Inc. (“Option Care”) and BioScrip, Inc. (“BioScrip”) organizations on August 6, 2019 to create Option Care Health, Inc. (“Option Care Health”...

BANNOCKBURN, Ill., Oct. 16, 2019 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent national provider of home and alternate site infusion services, today announced that the Company will release results for its third quarter ended September 30, 2019 on Wednesday, November 6, 2019 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details The...

...

...

...

...

Milberg Tadler Phillips Grossman LLP Announces Investigation of BioScrip, Inc. PR Newswire NEW YORK, March 8, 2018 NEW YORK , March 8, 2018 /PRNewswire/ -- Milberg Tadler Phillips Grossman LLP, an investor protection firm, has commenced an investigation of Denver, Colorado -based BioScrip, Inc. (BIOS) regarding possible violations of federal securities laws. On March 8, 2018 , BioScrip announced in its release of fourth quarter and full year financial results an ongoing internal accounting...

BIOSCRIP INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In BioScrip Inc. To Contact The Firm PR Newswire NEW YORK, March 8, 2018 NEW YORK , March 8, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against BioScrip Inc. ("BioScrip" or the "Company") (NASDAQ: BIOS). If you invested in BIOS stock or options and would like to discuss your legal rights, click here :...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioScrip, Inc. - BIOS PR Newswire NEW YORK, March 8, 2018 NEW YORK , March 8, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BioScrip, Inc. ("BioScrip" or the "Company") (NASDAQ: BIOS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The investigation concerns whether BioScrip and certain of its officers and/or...

BioScrip, Inc. (BIOS) Investigated By Block & Leviton LLP For Violations Of The Federal Securities Laws PR Newswire BOSTON, March 8, 2018 BOSTON , March 8, 2018 /PRNewswire/ -- Block & Leviton LLP ( www.blockesq.com ), a securities litigation firm representing investors nationwide, is investigating whether BioScrip, Inc. ("BioScrip" or the "Company") (NASDAQ: BIOS) and certain of its officers and directors violated federal securities laws. On March 8, 2018 , BioScrip released its preliminary...

NEW YORK, NY / ACCESSWIRE / November 2, 2017 / BioScrip, Inc. (NASDAQ: BIOS ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 2, 2017 at 9:00 AM Eastern Time. To listen to the event live or access a replay of the call - visit: https://www.investornetwork.com/company/23553 To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile. About Investor Network Investor...

NEW YORK, NY / ACCESSWIRE / August 8, 2017 / BioScrip, Inc. (NASDAQ: BIOS ) will be discussing their earnings results in their Q2 Earnings Call to be held on Tuesday, August 8, 2017 at 9:00 AM Eastern Time. To listen to the event live - visit https://www.investornetwork.com/company/23553 . Replay Information The replay will be available online at https://www.investornetwork.com/company/23553 . About Investor Network Investor Network (IN) is a new financial content community, serving millions of...

NEW YORK, NY / ACCESSWIRE / May 4, 2017 / BioScrip, Inc. (NASDAQ: BIOS ) will be discussing their earnings results in their Q1 Earnings Call to be held May 4, 2017 at 9:00 AM Eastern Time. To listen to the event live – visit https://www.investornetwork.com/company/23553 . Replay Information The replay will be available online at https://www.investornetwork.com/company/23553 . About Investor Network Investor Network (IN) is a new financial content community, serving millions of unique investors...

VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global ......

DENVER, Jan. 06, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that it has entered into an agreement to amend its existing Credit Agreement (the “Amendment”), dated July 31, 2013, among BioScrip, the guarantors, SunTrust Bank as administrative agent, and a syndicate of lenders. Additionally, BioScrip and the guarantors under the existing Credit Agreement...

DENVER, Dec. 14, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that it has introduced a proposed Amendment to its Credit Agreement (the “Amendment”) intended to amend the original Credit Agreement, dated July 31, 2013, among BioScrip, the guarantors, SunTrust Bank as administrative agent, and a syndicate of lenders. The proposed Amendment would reduce the...